Back to Retatrutide research
retatrutide gip agonist review 2026-04-03 PubMed

PEER Team Identifies Key 2023 Research for Primary Care Practice

Top studies of 2023 relevant to primary care: From the PEER team.

Background

Navigating the vast landscape of new medical research is a significant challenge for primary care practitioners. Staying abreast of the most impactful findings is crucial for delivering evidence-based care and improving patient outcomes. This review aimed to synthesize and highlight the most significant research published in 2023 that directly impacts primary care, addressing the challenge of information overload for busy clinicians.


retatrutide gip agonist glp 1 agonist glucagon agonist protocol relevant
Source: pubmed:38626998 · Ingested 2026-04-03 · Digest: gemini-2.5-flash